Evaluation of the effects of azithromycin and platelet-rich fibrin on wound healing after surgical removal of mandibular third molars
| ISRCTN | ISRCTN36568405 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN36568405 |
| Sponsor | Medical Faculty, University of Niš |
| Funder | University of Niš |
- Submission date
- 20/05/2026
- Registration date
- 22/05/2026
- Last edited
- 21/05/2026
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Oral Health
Plain English summary of protocol
Not provided at time of registration
Contact information
Principal investigator
Blv. Dr Zorana Đinđića 52
Niš
18000
Serbia
| Phone | +381638626663 |
|---|---|
| milan.spasic@medfak.ac.rs |
Scientific
Blv. Dr Zorana Đinđića 52
Niš
18000
Serbia
| Phone | +381642373966 |
|---|---|
| milica.petrovic@medfak.ac.rs |
Scientific
Blv. Dr Zorana Đinđića 52
Niš
18000
Serbia
| Phone | +3810184226216 |
|---|---|
| milan.stojiljkovic@medfak.ni.ac.rs |
Public
Blv. Dr Zorana Đinđića 52
Niš
18000
Serbia
| Phone | +381692245322 |
|---|---|
| simona.stojanovic@medfak.ac.rs |
Scientific
Blv. Dr Zorana Đinđića 52
Niš
18000
Serbia
| Phone | +3810184226216 |
|---|---|
| milos.kostic@medfak.ni.ac.rs |
Scientific
Blv. Dr Zorana Đinđića 52
Niš
18000
Serbia
| Phone | +3810184226216 |
|---|---|
| nikola.zivkovic@medfak.ni.ac.rs |
Study information
| Primary study design | Interventional |
|---|---|
| Allocation | Randomized controlled trial |
| Masking | Blinded (masking used) |
| Control | Active |
| Assignment | Crossover |
| Purpose | Health services research, Supportive care, Treatment |
| Scientific title | Cytomorphometric, immunological, and clinical analysis of the effects of azithromycin and platelet-rich fibrin on postoperative wound healing following surgical extraction of impacted mandibular third molars |
| Study acronym | APRIM Study |
| Study objectives | This study was conducted to evaluate the influence of azithromycin and platelet-rich fibrin (PRF) on postoperative inflammatory parameters and healing outcomes after extraction of impacted mandibular third molars, relative to routine treatment, by means of cytomorphometric, immunohistochemical, and clinical evaluations. |
| Ethics approval(s) |
1. Approved 20/02/2024, Ethics committe, Medical Faculty, University of Niš (Blv. Dr Zorana Đinđića 81, Niš, 18000, Serbia; +381184226644; info@medfak.ni.ac.rs), ref: 12/1760-1/2-5 2. Approved 19/01/2024, Ethics committee, Clinics Of Dentistry Niš (Blv. Dr Zorana Đinđića 52, Niš, 18000, Serbia; +381184226216; stomatolog_nis@kzsnis.rs), ref: 14/1-2023-3/EO |
| Health condition(s) or problem(s) studied | Surgical extraction of impacted mandibular third molar |
| Intervention | Participants were randomly allocated into three study groups using computer-generated randomisation. Group assignments were placed in sequentially numbered, sealed opaque envelopes, which were opened at the time of intervention allocation. Intervention description Control group: Participants received standard postoperative therapy consisting of oral amoxicillin 500 mg every 8 hours for 5 days following surgical extraction of vertically impacted mandibular third molars (standard protocol). PRF group: Following extraction and socket debridement, platelet-rich fibrin (PRF) prepared from autologous venous blood was placed into the extraction socket. Participants additionally received standard postoperative oral amoxicillin therapy (500 mg every 8 hours for 5 days). PRF + azithromycin group: Participants received a single prophylactic oral dose of azithromycin (1 g) one day before surgery. Following extraction and socket debridement, PRF prepared from autologous venous blood was placed into the extraction socket. Standard postoperative oral amoxicillin therapy (500 mg every 8 hours for 5 days) was also administered. PRF preparation protocol: Twenty millilitres of venous blood were collected into sterile tubes without anticoagulant and centrifuged at 1300 rpm (200 × g) for 14 minutes using a fixed-angle rotor centrifuge. The PRF clot was isolated and placed into the extraction socket within 15 minutes after centrifugation. |
| Intervention type | Procedure/Surgery |
| Primary outcome measure(s) |
|
| Key secondary outcome measure(s) |
|
| Completion date | 03/02/2026 |
Eligibility
| Participant type(s) | |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Upper age limit | 50 Years |
| Sex | All |
| Target sample size at registration | 90 |
| Total final enrolment | 124 |
| Key inclusion criteria | Vertically impacted third molars that are radiographically diagnosed according to Winter’s classification |
| Key exclusion criteria | 1. Allergies to penicillin or lidocaine 2. Chronic systemic diseases 3. Cystic lesions 4. Infections around the impacted third molar, odontomas, or syndromes affecting the orofacial region |
| Date of first enrolment | 03/04/2024 |
| Date of final enrolment | 29/09/2025 |
Locations
Countries of recruitment
- Serbia
Study participating centres
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Other files | 21/05/2026 | No | No | ||
| Statistical Analysis Plan | 21/05/2026 | No | No |
Additional files
- 49568_Informed Consent Form.pdf
- Other files
- 49568_SAP.pdf
- Statistical Analysis Plan
Editorial Notes
21/05/2026: Study’s existence confirmed by the Ethics committee, Clinics Of Dentistry Niš, Serbia.